EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactobacillus rhamnosus GG Administration Is Associated with Stimulation of Vitamin D/VDR Pathway and Mucosal Microbiota Modulation in Ulcerative Colitis Patients: A Pilot Study

Cristiano Pagnini iD, Manuele Gori iD, Maria Carla Di Paolo, Riccardo Urgesi, Claudia Cicione iD, Maria Zingariello, Francesca Arciprete, Viola Velardi, Elisa Viciani iD, Antonella Padella, Andrea Castagnetti iD, Maria Giovanna Graziani und 1 weitere

Pharmaceuticals · 01.11.2025 · 18 (11) · 1651

DOI: 10.3390/ph18111651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 01.11.2025. Verfasst von Cristiano Pagnini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Digestive Endoscopy Department, S. Giovanni Addolorata Hospital, 00184 Rome, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The interaction between probiotics and the vitamin D/vitamin D receptor (VDR) pathway has been increasingly explored as a potential mechanism for immune modulation in inflammatory bowel disease (IBD). Lactobacillus rhamnosus GG (LGG) has shown promising results in ulcerative colitis (UC) patients, but its effect on the VDR pathway remains unexplored in humans.

Aim

To test the hypothesis that LGG can stimulate the vitamin D/VDR pathway and modulate mucosal-adherent microbiota.

Methods

In this study, we analyzed a subgroup of 13 patients from the LGGinUC trial, in which UC patients with mild-to-moderate disease activity received LGG monotherapy for four weeks. Colonic biopsy samples were collected before and after treatment to evaluate VDR expression via RT-qPCR and immunohistochemistry. Mucosal-adherent microbiota was also analyzed by DNA extraction and next-generation sequencing (NGS).

Results

LGG administration significantly increased VDR mRNA expression in colonic mucosa (p < 0.05), with a corresponding rise in VDR protein levels in both epithelial and sub-epithelial compartments. Microbiota analysis revealed a reduction in α-diversity, primarily due to a decrease in commensal bacterial species, while β-diversity remained largely unchanged.

Conclusions

Although the present results have to be considered preliminary, this is the first human study demonstrating that probiotic supplementation can upregulate VDR expression in colonic mucosa. We propose that LGG may exert its beneficial effects in UC by stimulating the VDR pathway, which in turn modulates mucosal immunity and microbiota composition. Further studies with larger sample sizes and longer treatment durations are needed to validate these findings and explore their therapeutic implications.

Schlagwörter

Stichwörter der Autor:innen

LGGLactobacillus rhamnosus GGVDRmicrobiotaprobioticvitamin Dvitamin D receptor

Autor:innen und Institutionen

  • Gastroenterology and Digestive Endoscopy Department, S. Giovanni Addolorata Hospital, 00184 Rome, Italy.
  • Institute of Biochemistry and Cell Biology (IBBC)-National Research Council (CNR), International Campus "A. Buzzati-Traverso", Via E. Ramarini 32, Monterotondo Scalo, 00015 Rome, Italy.
  • Laboratory of Regenerative Orthopaedic, Research Unit of Orthopaedic Surgery, Campus Bio-Medico University of Rome, Via A. del Portillo 21, 00128 Rome, Italy.
  • Unit of Microscopic and Ultrastructural Anatomy, Department of Medicine, Campus Bio-Medico University of Rome, Via A. del Portillo 21, 00128 Rome, Italy.
  • Wellmicro Srl, 40138 Bologna, Italy.
  • Department of Gastroenterology, "Sapienza" University of Rome, 00185 Rome, Italy.

ORCID-Profile: Cristiano Pagnini, Manuele Gori, Claudia Cicione, Elisa Viciani, Andrea Castagnetti

Zitieren

APA

Pagnini, C., Gori, M., Di Paolo, M. C., Urgesi, R., Cicione, C., Zingariello, M., Arciprete, F., Velardi, V., Viciani, E., Padella, A., Castagnetti, A., Graziani, M. G., & Delle Fave, G. (2025). Lactobacillus rhamnosus GG Administration Is Associated with Stimulation of Vitamin D/VDR Pathway and Mucosal Microbiota Modulation in Ulcerative Colitis Patients: A Pilot Study. Pharmaceuticals, 18(11), 1651. https://doi.org/10.3390/ph18111651

Vancouver

Pagnini C, Gori M, Di Paolo MC, Urgesi R, Cicione C, Zingariello M, et al. Lactobacillus rhamnosus GG Administration Is Associated with Stimulation of Vitamin D/VDR Pathway and Mucosal Microbiota Modulation in Ulcerative Colitis Patients: A Pilot Study. Pharmaceuticals. 2025;18(11):1651. doi:10.3390/ph18111651

BibTeX
@article{Pagnini2025,
  author = {Pagnini, Cristiano and Gori, Manuele and Di Paolo, Maria Carla and Urgesi, Riccardo and Cicione, Claudia and Zingariello, Maria and Arciprete, Francesca and Velardi, Viola and Viciani, Elisa and Padella, Antonella and Castagnetti, Andrea and Graziani, Maria Giovanna and Delle Fave, Gianfranco},
  title = {Lactobacillus rhamnosus GG Administration Is Associated with Stimulation of Vitamin D/VDR Pathway and Mucosal Microbiota Modulation in Ulcerative Colitis Patients: A Pilot Study},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {11},
  pages = {1651},
  doi = {10.3390/ph18111651}
}
Kostenlos starten →